Document Detail


Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.
MedLine Citation:
PMID:  23934275     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, progressive hematopoietic stem cell disorder characterized by chronic complement-mediated hemolysis leading to life-threatening complications and early mortality. Eculizumab, a humanized anti-C5 monoclonal antibody, inhibits terminal complement activation, reduces hemolysis, decreases the risk of thrombosis, and improves renal function and quality of life in PNH patients. The long-term efficacy and safety of eculizumab in Japanese patients were assessed in a 2-year extension to a 12-week, open-label study (AEGIS). Eculizumab treatment led to an immediate and sustained reduction in intravascular hemolysis (P < 0.001) and red blood cell transfusions (P = 0.0016) compared with baseline levels. There were no reports of thromboembolism during eculizumab treatment. The majority of patients had stable (56 %) or improved (41 %) renal function and an improved quality of life (P = 0.015), with sustained reductions in fatigue and dyspnea. Eculizumab was well tolerated; no deaths or serious hemolytic events were reported, and the rate of infections declined over time. There were no significant differences in the response to eculizumab in patients with or without bone marrow dysfunction. These results demonstrate that eculizumab is an effective, well-tolerated long-term treatment for Japanese PNH patients and leads to continued amelioration of some hemolytic complications.
Authors:
Yuzuru Kanakura; Kazuma Ohyashiki; Tsutomu Shichishima; Shinichiro Okamoto; Kiyoshi Ando; Haruhiko Ninomiya; Tatsuya Kawaguchi; Shinji Nakao; Hideki Nakakuma; Jun-Ichi Nishimura; Taroh Kinoshita; Camille L Bedrosian; Keiya Ozawa; Mitsuhiro Omine
Related Documents :
8434515 - Continuous irrigation-drainage of the subdural space for the treatment of chronic subdu...
24596235 - Comparison of long-term quality-of-life outcomes in vestibular schwannoma patients.
23486745 - Comparison of colonic j-pouch and straight coloanal anastomosis after low anterior rese...
24843095 - Short-term follow-up of quality-of-life in interventionally treated patients with post-...
23610195 - Performance analysis of a world-class sprinter during cycling grand tours.
23062575 - Long-term treatment with tetrahydrobiopterin in phenylketonuria: treatment strategies a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-11
Journal Detail:
Title:  International journal of hematology     Volume:  -     ISSN:  1865-3774     ISO Abbreviation:  Int. J. Hematol.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-8-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111627     Medline TA:  Int J Hematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Hematology and Oncology, Osaka University Hospital, Suita, Japan, kanakura@bldon.med.osaka-u.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adherence and Weight Loss Outcomes in Bariatric Surgery: Does Cognitive Function Play a Role?
Next Document:  Multimode Resistive Switching in Single ZnO Nanoisland System.